Ishihara Sangyo Kaisha (4028) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
12 May, 2026Executive summary
Net sales rose 6.7% year-over-year to ¥154,897 million for the fiscal year ended March 31, 2026.
Operating profit increased 82.0% to ¥19,077 million, and ordinary profit surged 90.8% to ¥21,737 million year-over-year.
Profit attributable to owners of parent more than doubled to ¥16,636 million, up 97.8% year-over-year.
Comprehensive income reached ¥18,940 million, a 73.8% increase from the previous year.
Financial highlights
Gross profit improved to ¥49,666 million from ¥39,531 million year-over-year.
Basic earnings per share rose to ¥434.78 from ¥219.98 year-over-year.
Equity-to-asset ratio increased to 53.7% from 50.8% year-over-year.
Cash and cash equivalents at period end were ¥29,424 million, up from ¥24,948 million.
Net assets per share increased to ¥3,370.85 from ¥2,986.82 year-over-year.
Outlook and guidance
FY2027 net sales forecasted at ¥150,000 million, a 3.2% decrease year-over-year.
Operating profit expected to decline 25.6% to ¥14,200 million; profit attributable to owners of parent projected to fall 45.3% to ¥9,100 million.
Full-year EPS forecasted at ¥237.82.
Latest events from Ishihara Sangyo Kaisha
- Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 202613 Feb 2026 - Net sales grew 10.4% year-over-year, but net income fell sharply by 80.6%.4028
Q2 202520 Nov 2025 - Q1 FY2025 profit dropped over 40% year-over-year despite stable sales; outlook revised down.4028
Q1 202520 Nov 2025 - Sales and operating income rose, but net income fell; dividend forecast increased.4028
Q3 202520 Nov 2025 - Net sales up 4.9% year-over-year, with profit and dividend growth forecast for FY2026.4028
Q4 202520 Nov 2025 - Operating profit surged 191% year-over-year, with strong sales and raised full-year guidance.4028
Q1 202620 Nov 2025 - Operating profit and net income surged, with robust outlook and higher full-year forecasts.4028
Q2 202620 Nov 2025